Why hives keep coming back, and what the trials say actually calms them
Chronic hives can flare for months with no allergy to find. A Cochrane review of 9,759 people found modern antihistamines such as cetirizine clear them in a minority, not everyone.
Hives are red and sometimes itchy bumps on the skin, and in the version most people meet they turn up once — after a new drug or a particular food — and fade [s3]. The frustrating kind is the one that keeps coming back for weeks with no trigger anyone can pin down. The honest news on that is mixed: the standard treatment is safe and cheap, but the trials show it fully clears hives in a minority of people, not all [s1].
What hives actually are
An allergic reaction to a drug or food usually causes hives, and other causes include infections and stress [s3]. The international urticaria guideline — a joint effort of European and Asia-Pacific allergy and dermatology societies — describes urticaria as a frequent, mast cell-driven disease that presents with wheals, angioedema, or both [s2]. The mast cell is the key: these immune cells release histamine into the skin, which is what raises the itchy weal, whether or not a true allergy set them off.
Short-lived hives are common. The guideline puts the lifetime prevalence of acute urticaria at approximately 20% — roughly one person in five at some point [s2].
When they will not stop
The version that sends people looking for answers is chronic spontaneous urticaria: in the words of a Cochrane review, the development of crops of red, itchy, raised weals or hives with no identifiable external cause [s1]. That last phrase is the source of much of the distress. People hunt for the food or detergent to blame, and often there is not one to find. The guideline is clear that chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school [s2] — this is not a trivial rash.
What the trials show helps
The mainstay is antihistamines, and Cochrane pooled the evidence: 73 studies enrolling 9,759 participants, of which 34 provided usable data across 23 comparisons [s1]. Most of the trials were short — the reviewers grouped them into treatment lasting up to two weeks and treatment running from two weeks to three months — so what is known is mostly about the first weeks of use, not the long haul [s1]. Their toughest yardstick was complete suppression of hives, alongside a "good or excellent" response and a 50%-or-greater improvement in quality-of-life scores [s1]. The useful signal is that modern, non-drowsy (second-generation) antihistamines outperform placebo — but the effect is partial.
Cetirizine at 10 mg once daily led to complete suppression of urticaria in more people than placebo did, both short-term and over an intermediate period, with a risk ratio of 2.72 (95% confidence interval 1.51 to 4.91) [s1]. Rupatadine at 10 mg and 20 mg produced a "good or excellent response" more often than placebo over the intermediate term (risk ratio 1.35, 95% CI 1.03 to 1.77) [s1]. Some comparisons looked dramatic but rested on very little data: desloratadine versus placebo, for instance, returned a risk ratio of 37.00 with a confidence interval running from 2.31 all the way to 593.70 — a range that wide means the true size of the benefit is highly uncertain [s1].
Read together, the review supports a familiar, reassuring conclusion: standard antihistamines are a reasonable first step and they help, but "complete suppression" is the exception rather than the rule, and how much any single drug helps is measured imprecisely [s1]. That is why chronic hives that resist an over-the-counter antihistamine are worth taking to a doctor, who can consider higher dosing or other options rather than leaving someone to cycle through brands.
The one pattern that is an emergency
Most hives are uncomfortable, not dangerous. The exception is important. MedlinePlus warns that, in rare cases, hives can cause a dangerous swelling in the airways, making it hard to breathe — which is a medical emergency [s3]. Hives accompanied by swelling of the lips, tongue or throat, trouble breathing or swallowing, faintness or a tight chest can be part of a severe allergic reaction and need emergency care, not an antihistamine and a wait.
For the ordinary itchy kind, hives that keep returning for more than a few weeks are worth a clinician's assessment. This article is informational and is not medical advice.
Sources
- H1-antihistamines for chronic spontaneous urticaria — Cochrane Database of Systematic Reviews, 2014-11-14
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria — Allergy, 2021-10-20
- Hives (MedlinePlus) — U.S. National Library of Medicine (MedlinePlus)
Sources
- H1-antihistamines for chronic spontaneous urticaria — Cochrane Database of Systematic Reviews , November 14, 2014
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria — Allergy , October 20, 2021
- Hives (MedlinePlus) — U.S. National Library of Medicine (MedlinePlus) , January 1, 2024
Hives that keep coming back are usually not an allergy — they are your own immune system
Chronic hives are mast-cell driven and usually have no external trigger. Antihistamines clear some cases; at 12 weeks omalizumab cut a weekly itch score by 9.8 points at 300 mg, against 5.1 on placebo.
Seborrhoeic dermatitis: antifungals and short steroid courses are what the trials back
The flaky, red patches on scalp, brows and nose folds are an inflammatory reaction, not poor hygiene. Ketoconazole cream cut treatment failure 31% against placebo, and short steroid courses tripled clearance.
Melasma is driven by sun and hormones on ageing skin — and no cream fully clears it
The brown facial patches come from overactive pigment cells in sun-aged skin. Triple-combination cream beats hydroquinone alone (risk ratio 1.58) and tranexamic acid helps, but relapse is the rule.
Chronic dry skin: moisturisers are the evidence-backed fix, but effects are modest
Xerosis is a barrier problem, not dirt. Cochrane found moisturisers cut eczema flares 60% and spared steroid use; in care-home residents a twice-daily emollient roughly halved skin tears, on weak evidence.